Bookbot
Questo è quello che aggiungi al carrello

Ernst Schering Research Foundation Workshop - 48: From Morphological Imaging to Molecular Targeting

Parametri

  • 196pagine
  • 7 ore di lettura

Maggiori informazioni sul libro

Inhaltsverzeichnis1 Molecular Imaging: Dream or Reality?.2 Target Discovery and Validation.3 Noninvasive Imaging in Drug Discovery and Development.4 Internal Dose Assessment — Extrapolation from Animal Species to the Human.5 PET for Drug Development.6 Future Directions in Molecular Imaging.7 Regulatory Implications — The EU Perspective.8 Nonclinical Development of Radiopharmaceuticals: Regulatory Considerations for the United States Food and Drug Administration.9 The Japanese Perspective on Radiopharmaceuticals.Previous Volumes Published in This Series.

Acquisto del libro

Ernst Schering Research Foundation Workshop - 48: From Morphological Imaging to Molecular Targeting, Markus Schwaiger, Ludger Dinkelborg, Hermann Schweinfurth

Lingua
Pubblicato
2004
product-detail.submit-box.info.binding
(Copertina rigida),
Condizioni del libro
In ottime condizioni
Prezzo
4,79 €

Metodi di pagamento

Ancora nessuna valutazione.Aggiungi una valutazione

Titolo
Ernst Schering Research Foundation Workshop - 48: From Morphological Imaging to Molecular Targeting
Editore
Springer
Pubblicato
2004
Formato
Copertina rigida
Pagine
196
ISBN10
3540201378
ISBN13
9783540201373
Serie
Tag
Saggistica, Salute & Medicina, Temi psicologici, Germania, Medicina, Letteratura specialistica, Ricerca, Libri, Biochimica, Farmacologia, Farmacia, Radiologia, Tossicologia, Ricerca medica, Medicina Nucleare
Descrizione
Inhaltsverzeichnis1 Molecular Imaging: Dream or Reality?.2 Target Discovery and Validation.3 Noninvasive Imaging in Drug Discovery and Development.4 Internal Dose Assessment — Extrapolation from Animal Species to the Human.5 PET for Drug Development.6 Future Directions in Molecular Imaging.7 Regulatory Implications — The EU Perspective.8 Nonclinical Development of Radiopharmaceuticals: Regulatory Considerations for the United States Food and Drug Administration.9 The Japanese Perspective on Radiopharmaceuticals.Previous Volumes Published in This Series.